Reductive metabolism of halothane in children

Area of Science:

• Anesthesiology
• Pharmacokinetics
• Toxicology

Background:

• Halothane is an inhalational anesthetic agent.
• Halothane hepatitis, a rare but severe adverse reaction, is less common in children than adults.
• The metabolic pathways of halothane, particularly the reductive pathway, are not fully understood in pediatric populations.

Purpose of the Study:

• To identify and quantify volatile halothane metabolites in the exhaled breath of children during anesthesia.
• To compare the metabolic profile of halothane in children to that previously reported in adults.
• To investigate whether differences in halothane metabolism contribute to the lower incidence of halothane hepatitis in children.

Main Methods:

• Ten pediatric patients undergoing halothane anesthesia were studied.
• Exhaled breath samples were collected during anesthesia.
• Volatile metabolites, 2-chloro-1,1,1,-trifluoroethane and 2-chloro-1,1-difluoroethylene, were identified and quantified.

Main Results:

• The volatile halothane metabolites, 2-chloro-1,1,1,-trifluoroethane and 2-chloro-1,1-difluoroethylene, were detected in the exhaled breath of all ten children.
• Exhaled concentrations of these metabolites varied among children but were comparable in magnitude to those found in adults.
• The time-course of metabolite exhalation also showed inter-individual variability.

Conclusions:

• Children effectively metabolize halothane via the reductive pathway, producing volatile metabolites similar to adults.
• The lower incidence of halothane hepatitis in children is unlikely due to an impaired ability to metabolize halothane through this pathway.
• Further research is needed to elucidate the reasons for the decreased risk of halothane hepatitis in pediatric patients.